Groove Biopharma

company

About

Groove Biopharma develops novel microRNA therapeutics for maladies including cancer, fibrosis and infectious diseases.

  • 1 - 10

Details

Last Funding Type
Series B
Last Funding Money Raised
$6M
Industries
Biopharma,Biotechnology,Health Care,Medical
Founded date
Jan 1, 2008
Number Of Employee
1 - 10
Operating Status
Active

Groove Biopharma focuses on the generation of novel microRNA (miRNA) therapeutics with improved properties, including higher potency and enhanced pharmacodynamic activity. Endogenous microRNAs (miRNAs) are involved in extensive regulatory networks for many target genes and pathways. Groove Biopharma’s core technology addresses a new avenue of nucleotide therapeutic drug discovery via modulation of cellular miRNA. Using exclusive technology, Groove Biopharma is generating a series of lead candidates with the potential to be best-in-class therapeutics. By incorporating proprietary structural modifications into miRNA therapeutics, the Groove Biopharma technology platform presents promising potential for treating a wide range of diseases, including cancer, fibrosis, and infectious disease.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$9.90M
Groove Biopharma has raised a total of $9.90M in funding over 2 rounds. Their latest funding was raised on Dec 12, 2011 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Dec 12, 2011 Series B $6M 2 Detail
Apr 26, 2010 Series A $3.90M 2 Detail

Investors

Number of Lead Investors
Number of Investors
2
Groove Biopharma is funded by 2 investors. ARCH Venture Partners and Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
ARCH Venture Partners Series B
Versant Ventures Series B